{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:27:30Z","timestamp":1791214050612,"version":"4.1.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1093\/brain\/awr217","type":"journal-article","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T00:54:47Z","timestamp":1315616087000},"page":"3167-3175","source":"Crossref","is-referenced-by-count":170,"title":["A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities"],"prefix":"10.1093","volume":"134","author":[{"given":"Fieke M.","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J.","family":"Titulaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob K.","family":"Sont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel R.","family":"Wintzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J. G. M.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh A.","family":"Badrising","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,9,9]]},"reference":[{"key":"key\n\t\t\t\t20170425173153_awr217-B1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.10121","article-title":"Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo","volume":"51","author":"Badrising","year":"2002","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425173153_awr217-B2","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.55.9.1385","article-title":"Epidemiology of inclusion body myositis in the Netherlands: a nationwide study","volume":"55","author":"Badrising","year":"2000","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425173153_awr217-B3","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s00415-005-0884-y","article-title":"Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients","volume":"252","author":"Badrising","year":"2005","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20170425173153_awr217-B4","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1212\/01.WNL.0000148588.15052.4C","article-title":"Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis","volume":"63","author":"Badrising","year":"2004","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425173153_awr217-B5","volume-title":"A clinicians view of neuromuscular disorders","author":"Brooke","year":"1986"},{"key":"key\n\t\t\t\t20170425173153_awr217-B6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1378\/chest.104.3.975","article-title":"Inclusion body myositis as a cause of respiratory failure","volume":"104","author":"Cohen","year":"1993","journal-title":"Chest"},{"key":"key\n\t\t\t\t20170425173153_awr217-B7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/03790799109166684","article-title":"The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment","volume":"13","author":"Collen","year":"1991","journal-title":"Int Disabil Stud"},{"key":"key\n\t\t\t\t20170425173153_awr217-B8","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00415-009-5229-9","article-title":"Detecting dysphagia in inclusion body myositis","volume":"256","author":"Cox","year":"2009","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20170425173153_awr217-B9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ncpneuro0261","article-title":"Sporadic inclusion body myositis-diagnosis, pathogenesis and therapeutic strategies","volume":"2","author":"Dalakas","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"key\n\t\t\t\t20170425173153_awr217-B10","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/brain\/awp104","article-title":"Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis","volume":"132","author":"Dalakas","year":"2009","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170425173153_awr217-B11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00005792-200109000-00006","article-title":"Inclusion body myositis in Connecticut: observations in 35 patients during an 8-year period","volume":"80","author":"Felice","year":"2001","journal-title":"Medicine"},{"key":"key\n\t\t\t\t20170425173153_awr217-B12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-0404.1994.tb01647.x","article-title":"Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 cases","volume":"89","author":"Lindberg","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"key\n\t\t\t\t20170425173153_awr217-B13","first-page":"61","article-title":"Functional evaluation; the Barthel index","volume":"14","author":"Mahoney","year":"1965","journal-title":"Md State Med J"},{"key":"key\n\t\t\t\t20170425173153_awr217-B14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(07)70171-0","article-title":"Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches","volume":"6","author":"Needham","year":"2007","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170425173153_awr217-B15","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/jnnp.2007.138891","article-title":"Sporadic inclusion body myositis: Phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases","volume":"79","author":"Needham","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170425173153_awr217-B16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/PHM.0b013e31818a50e2","article-title":"Dysphagia in inclusion body myositis","volume":"87","author":"Oh","year":"2008","journal-title":"Am J Phys Med Rehabil"},{"key":"key\n\t\t\t\t20170425173153_awr217-B17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.55.2.296","article-title":"Disease progression in sporadic inclusion body myositis: observations in 78 patients","volume":"55","author":"Peng","year":"2000","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425173153_awr217-B18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/ptj\/74.3.253","article-title":"Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements","volume":"74","author":"Personius","year":"1994","journal-title":"Phys Ther"},{"key":"key\n\t\t\t\t20170425173153_awr217-B19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004427.pub2","article-title":"Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease","author":"Radunovic","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20170425173153_awr217-B20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1212\/WNL.57.3.548","article-title":"A prospective natural history study of inclusion body myositis: implications for clinical trials","volume":"57","author":"Rose","year":"2001","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425173153_awr217-B21","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/jnnp.2009.183863","article-title":"What determines quality of life in inclusion body myositis?","volume":"81","author":"Sadjadi","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170425173153_awr217-B22","volume-title":"Aids to the examination of the peripheral nervous system","author":"Saunders","year":"2000"},{"key":"key\n\t\t\t\t20170425173153_awr217-B23","unstructured":"Statistics Netherlands Statistical yearbook of the Netherlands 2010 www@cbs.nl"},{"key":"key\n\t\t\t\t20170425173153_awr217-B24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-2008-1041132","article-title":"Inclusion body myositis: new concepts","volume":"13","author":"Sekul","year":"1993","journal-title":"Semin Neurol"},{"key":"key\n\t\t\t\t20170425173153_awr217-B25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.nmd.2004.09.006","article-title":"Diaphragmatic dysfunction in patients with ideopathic inflammatory myopathies","volume":"15","author":"Teixeira","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20170425173153_awr217-B26","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1056\/NEJMsa071143","article-title":"End-of-life practices in the Netherlands under the Euthanasia Act","volume":"356","author":"van der Heide","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170425173153_awr217-B27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jnnp.54.3.244","article-title":"Hand-held myometry: reference values","volume":"54","author":"van der Ploeg","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20170425173153_awr217-B28","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJMsa012739","article-title":"Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the Netherlands","volume":"346","author":"Veldink","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170425173153_awr217-B29","first-page":"81","article-title":"Inclusion body myositis","volume-title":"Diagnostic criteria for neuromuscular disorders","author":"Verschuuren","year":"1997"},{"key":"key\n\t\t\t\t20170425173153_awr217-B30","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1212\/01.WNL.0000145834.17020.86","article-title":"Primary respiratory failure in inclusion body myositis","volume":"63","author":"Voermans","year":"2004","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425173153_awr217-B31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1017\/S0317167100048770","article-title":"Dysphagia in ambulant patients with Parkinson's disease: common, not dangerous","volume":"21","author":"Wintzen","year":"1994","journal-title":"Can J Neurol Sci"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/134\/11\/3167\/13794782\/awr217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T15:18:58Z","timestamp":1503415138000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awr217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,9]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,9,9]]},"published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awr217","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9,9]]}}}